期刊文献+

宫颈上皮内瘤变p16^(INK4a)和p53及Ki-67表达及其诊断价值探讨 被引量:10

Expressions of p16^(INK4a),p53 and Ki-67 in cervical intraepithelial lesion by immunohistochemistry and their diagnostic and clinic significance
原文传递
导出
摘要 目的:探讨用p16和p53及Ki-67等免疫组化标记作为宫颈上皮内瘤变(CIN)诊断的辅助指标。方法:选取我院档案CIN患者133例,年龄20~86岁,中位年龄46岁。经3位高年资病理医师复查确认,其中CIN 1级31例、CIN 2级37例和CIN 3级65例。另选同期我院宫颈慢性炎患者19例,浸润性鳞状细胞癌患者20例作为对照。采用SP法进行p16、p53和Ki-67免疫组化染色,结果独立评分。各级别CIN与免疫组化表达的关系采用单变量χ2检验和Spearman等级相关分析。结果:p16阳性表达位于细胞核或胞核伴胞质,p53和Ki-67定位于细胞核。p16、p53和Ki-67表达阳性率随着CIN的加重而升高,均与CIN级别呈正相关,r值分别为0.789、0.554和0.749,P<0.001。153例CIN 1+标本中p16、p53和Ki-67与组织学诊断符合率分别为96.7%(148/153)、71.9%(110/153)和88.2%(135/153)。在102例CIN 2+标本中,p16、p53和Ki-67免疫组化染色的敏感性分别为97.1%(99/102)、74.5%(76/102)和97.1%(99/102);特异性分别为94.7%(18/19)、84.2%(16/19)和73.7%(14/19)。p16、p53和Ki-67 3者联合在CIN 2+中的敏感性和特异性分别为98.0%(100/102)、68.4%(13/19)。结论:在宫颈活检的组织学评价时,结合p16、p53和Ki-67免疫组化染色,对提高高级别CIN的检出率、减少漏诊有很大作用。 OBJECTIVE:To explore immunohistochemistry staining for p16INK4a,p53 and Ki-67 as adjunct indicators for cervical intraepithelial neoplasia(CIN) diagnosis,improving the routine interpretation of cervical histopathology.METHODS:Totally 133 cases of CIN were involoved in this study,which consisted of 31 CIN 1,37 CIN 2,65 CIN 3 from archival data in our hospital.The average age was 44 years(range 20-86 years).All hematoxylin-eosin slides were reexamined independently by three senior pathologists.Nineteen cases of chronic cervicitis and 20 cases of invasive squamous cell carcinoma were involved as controls.Immunostains for p16INK4a,p53 and Ki-67 were performed.The expressions of immunostain were scored independent of the corresponding SP stained sections and clinical data except age.Statistical analysis was performed by Univariate χ2 tests and Spearman analysis.RESULTS: The expression of p16 was located in nucleus and cytoplasm.For p53 and Ki-67,were located in nucleus.All three biomarkers correlated positively with the grading of CIN(r were 0.789,0.554 and 0.749,P0.001).In 153 cases of CIN1+,raw agreement between the expression of p16,p53 and Ki-67,and histological diagnosis was 96.7%(148/153),71.9%(110/153) and 88.2%(135/153),respectively.In 102 cases with CIN 2+,sensitivity for p16,p53 and Ki-67 immunostain was 97.1%(99/102),74.5%(76/102) and 97.1%(99/102),respectively.And specificity for these biomarkers was 94.7%(18/19),84.2%(16/19) and 73.7%(14/19),respectively.Combined the three biomarkers,the sensitivity and specificity of CIN 2+ was 98.0%(100/102) and 68.4%(13/19),respectively.CONCLUSIONS: Immunohistochemical staining for p16 is a high degree of sensitivity,and specificity appears to be a useful and reliable diagnostic adjunct for distinguishing high-grade CIN.It appears that conjunctive interpretation of p16,p53 and Ki-67 can significantly improve the routine interpretation of cervical histopathology.
出处 《中华肿瘤防治杂志》 CAS 2011年第16期1255-1258,共4页 Chinese Journal of Cancer Prevention and Treatment
基金 南通市社会发展科技计划项目(S2009050)
关键词 宫颈上皮内瘤样病变/病理学 宫颈肿瘤/病理学 P16INK4A P53 Ki-67 免疫组织化学 cervical intraepithelial neoplasia/pathology cervix neoplasms/pathology p16INK4a p53 Ki-67 immunohistochemistry
  • 相关文献

参考文献12

二级参考文献64

共引文献54

同被引文献48

  • 1Ferlay J, Shin HR, Bray F, et al. GLOBOCAN 2008, cancer incidence and mortality worldwide: IARC cancer base No. 10. Lyon, France: international agency for research on cancer, 2010. Available at http:// globocan. iarc. fr. 被引量:1
  • 2De Sanjose S, Quint WG, Alemany L, et al. Human papilloma virus genotype attribution in invasive cervical cancer: a retro spective cross-sectional worldwide study[J]. Lancet Oncol,2010 11: 1048-1056. 被引量:1
  • 3Ronco G, Giorgi-Rossi P, Carozzi F, et al. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial[J]. Lancet Oncol, 2010, 11(3): 249-257. 被引量:1
  • 4Belinson JL, Qiao YL, Pretorius RG, et al. Shanxi Province cervical cancer screening study Ⅱ: sell-sampling for high-risk human papillomavirus compared to direct sampling for human papillomavirus and liquid based cervical cytology[J]. Int J Gyne col Cancer, 2003, 13(6) : 819-826. 被引量:1
  • 5Depuydt CE, Makar AP, Ruymbeke MJ, et al. BD-ProExC as adjunct molecular marker for improved detection of CIN2+ after HPV primary screening[J]. Cancer Epidemiol Biomarkers Prey, 2011, 20(4) :628-637. 被引量:1
  • 6Hesselink AT, Heideman DA, Steenbergen RD, et al. Combined promoter methylation analysis of CADM1 and MAL: an objective triage tool for high-risk human papillomavirus DNA- positive women[J]. Clin Cancer Res, 2011, 17(8): 2459-2465. 被引量:1
  • 7Dobrzycka B, Terlikowski S J, Garbowicz M. The prognostic significance of the immunohistochemical expression of P53 and BCL-2 in endometrial cancer [J]. Folia Histochem Cytobiol,2011, 49(4) :631-635,. 被引量:1
  • 8Yi J, Luo J. SIRT1 and p53, effect on cancer, senescence and beyond [J]. Biochim Biophys Acta,2010,1804 ( 8 ) : 1684-1689. 被引量:1
  • 9Tavassoli FA, Devilee P. World Health Organization: Tumours of the breast and female genital organs [M]. 3rd ed. Lyon: IARC Press-WHO ,2003:221-227. 被引量:1
  • 10Maiese K, Chong ZZ, Shang YC, et al. Translating cell survival and cell longevity into treatment strategies with SIRT1. [J]. Rom J Morphol Embryol,2011,52 (4) : 1173-1185. 被引量:1

引证文献10

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部